Pulmatrix Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$3.95 |
Market Cap |
$7.51 M |
Shares Outstanding |
18.29 M |
Public Float |
7.68 M |
Address |
99 Hayden Avenue Lexington Massachusetts 02421 United States |
Employees | - |
Website | http://www.pulmatrix.com |
Updated | 07/08/2019 |
Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the discovery and development of novel inhaled therapeutic products. The company focuses on the prevention and treatment of respiratory diseases and infections. It offers products based on its proprietary dry powder delivery technology, iSPERSE, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. |